Small Molecules - Solid State Research and Development
The Eurofins CDMO (Contract Development & Manufacturing Organization) network of companies has expanded its capabilities through Solid State Research and Development (SSRD) services in support of API and FDF developmental programs.
With more than fifteen years of experience in physicochemical characterization of solid state APIs and advanced intermediates as well as screening for different API solid forms, our team of highly qualified scientists in Solid State Science (crystallography, material science, formulation) offer quality by design approach for small molecule APIs at different phases of pharmaceutical development.
To support API solid form Research & Development programs, we apply High-Throughput Screening Technology (HTST) for expeditious discovery of new polymorphs, pharmaceutical salts, solvates, co-crystals, particle size engineering and development or automated crystallization scale-up development. Some of the benefits of the HTST include a reduction in cost, manpower, time and a 100s-fold reduction in API quantities required for studies. A combination of the HTS robotic station for crystallization screening (Unchained Labs Junior) and a multi-sample PXRD equipment (Bruker D8 Discover HTS) enables concurrent analysis of up to 400 samples.
Through the integration of synthetic process R&D, solid state R&D, preformulation and formulation development, we are providing a knowledge-based quality by design approach throughout the API development and manufacturing.
